An Inherited Genetic Variant inCEP72Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia

Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population

(2016) Angela Gutierrez-Camino et al.   Pharmacogenetics and Genomics

Vincristine pharmacogenomics

(2016) Barthelemy Diouf et al.   Pharmacogenetics and Genomics

Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

(2015) Barthelemy Diouf et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Toxicity of Cancer Therapy in Adolescents and Young Adults (AYAs)

(2015) Andrew J. Bukowinski et al.   Seminars in Oncology Nursing

Chemotherapy-induced neuropathy: A comprehensive survey

(2014) N.C. Miltenburg et al.   CANCER TREATMENT REVIEWS

Chemotherapy-induced peripheral neurotoxicity: A critical analysis

(2013) Susanna B. Park et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol

(2013) Elena Liew et al.   LEUKEMIA RESEARCH

Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia

(2012) Wendy Stock et al.   CANCER

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients

(2007) Jamie L. Renbarger et al.   PEDIATRIC BLOOD & CANCER